Anpario plc (LON:ANP – Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 415.01 ($5.58) and traded as low as GBX 395 ($5.31). Anpario shares last traded at GBX 410 ($5.51), with a volume of 96,774 shares.
Analyst Upgrades and Downgrades
Separately, Shore Capital reissued a “house stock” rating on shares of Anpario in a research note on Monday, March 31st.
Get Our Latest Analysis on ANP
Anpario Stock Performance
Anpario (LON:ANP – Get Free Report) last announced its earnings results on Monday, March 31st. The company reported GBX 28.40 ($0.38) EPS for the quarter. Anpario had a net margin of 9.23% and a return on equity of 8.74%. On average, equities research analysts predict that Anpario plc will post 23.5757801 earnings per share for the current year.
Anpario Increases Dividend
The business also recently disclosed a dividend, which will be paid on Friday, July 25th. Shareholders of record on Thursday, July 10th will be given a GBX 8 ($0.11) dividend. This is a positive change from Anpario’s previous dividend of $3.25. The ex-dividend date is Thursday, July 10th. This represents a yield of 2.09%. Anpario’s payout ratio is currently 60.74%.
Insiders Place Their Bets
In other Anpario news, insider Marc Wilson bought 3,778 shares of Anpario stock in a transaction dated Tuesday, April 1st. The stock was purchased at an average price of GBX 398 ($5.35) per share, for a total transaction of £15,036.44 ($20,221.14). Insiders own 30.51% of the company’s stock.
Anpario Company Profile
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Further Reading
- Five stocks we like better than Anpario
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
- How to Use the MarketBeat Excel Dividend Calculator
- Overheated Market? Analysts Watch These Red Flags
- What is the S&P/TSX Index?
- 3 Reasons AMD Could Be the Hottest Stock of the Summer
Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.